$YTENQ
YIELD10 BIOSCIENCE, INC.

2019 Q3 Form 10-Q Financial Statement

#000112170219000025 Filed on August 12, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $224.0K $318.0K $285.0K
YoY Change 194.74% 11.58% -2.73%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $990.0K $1.025M $1.456M
YoY Change -30.13% -29.6% -21.97%
% of Gross Profit
Research & Development $1.230M $1.190M $1.260M
YoY Change -8.21% -5.56% 10.53%
% of Gross Profit
Depreciation & Amortization $50.00K $50.00K $50.00K
YoY Change 0.0% 0.0% -16.67%
% of Gross Profit
Operating Expenses $990.0K $1.025M $1.456M
YoY Change -30.13% -29.6% -21.97%
Operating Profit -$1.998M -$1.898M -$2.431M
YoY Change -25.34% -21.93% -10.33%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $16.00K $27.00K $38.00K
YoY Change -57.89% -28.95% -337.5%
Pretax Income -$1.982M -$1.871M -$2.390M
YoY Change -24.92% -21.72% -12.45%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.982M -$1.871M -$2.393M
YoY Change -24.87% -21.81% -12.34%
Net Earnings / Revenue -884.82% -588.36% -839.65%
Basic Earnings Per Share
Diluted Earnings Per Share -$6.387M -$6.032M -$9.560M
COMMON SHARES
Basic Shares Outstanding 12.52M shares 12.49M shares 9.968M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.900M $4.300M $9.700M
YoY Change -62.82% -55.67% 223.33%
Cash & Equivalents $2.877M $3.252M $3.168M
Short-Term Investments $0.00 $1.000M $6.500M
Other Short-Term Assets $500.0K $500.0K $400.0K
YoY Change 25.0% 25.0% -20.0%
Inventory
Prepaid Expenses
Receivables $71.00K $148.0K $29.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.499M $5.017M $10.10M
YoY Change -57.66% -50.35% 158.55%
LONG-TERM ASSETS
Property, Plant & Equipment $1.247M $1.298M $1.477M
YoY Change -13.1% -12.12% -9.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $31.00K $42.00K $98.00K
YoY Change -70.75% -57.14% 3.16%
Total Long-Term Assets $5.920M $6.139M $7.116M
YoY Change 216.07% -13.73% 229.44%
TOTAL ASSETS
Total Short-Term Assets $3.499M $5.017M $10.10M
Total Long-Term Assets $5.920M $6.139M $7.116M
Total Assets $9.419M $11.16M $17.22M
YoY Change -7.08% -35.21% 183.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.00K $55.00K $34.00K
YoY Change 30.77% 61.76% -51.43%
Accrued Expenses $905.0K $586.0K $871.0K
YoY Change -48.87% -32.72% -67.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.754M $1.506M $1.489M
YoY Change -3.04% 1.14% -46.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.000M $5.200M $900.0K
YoY Change 400.0% 477.78% -18.18%
Total Long-Term Liabilities $5.000M $5.200M $900.0K
YoY Change 400.0% 477.78% -18.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.754M $1.506M $1.489M
Total Long-Term Liabilities $5.000M $5.200M $900.0K
Total Liabilities $6.799M $6.702M $2.430M
YoY Change 142.04% 175.8% -36.5%
SHAREHOLDERS EQUITY
Retained Earnings -$358.1M -$356.1M -$347.4M
YoY Change 2.28% 2.49% 2.74%
Common Stock $360.8M $360.6M $357.1M
YoY Change 0.92% 0.99% 4.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.620M $4.454M $9.576M
YoY Change
Total Liabilities & Shareholders Equity $9.419M $11.16M $17.22M
YoY Change -7.08% -35.21% 183.78%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$1.982M -$1.871M -$2.393M
YoY Change -24.87% -21.81% -12.34%
Depreciation, Depletion And Amortization $50.00K $50.00K $50.00K
YoY Change 0.0% 0.0% -16.67%
Cash From Operating Activities -$1.370M -$1.780M -$1.860M
YoY Change -25.54% -4.3% 0.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K -$30.00K
YoY Change -100.0% -66.67%
Acquisitions
YoY Change
Other Investing Activities $1.000M -$1.000M -$2.500M
YoY Change -50.0% -60.0%
Cash From Investing Activities $990.0K -$1.010M -$2.530M
YoY Change -50.25% -60.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -20.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.370M -1.780M -1.860M
Cash From Investing Activities 990.0K -1.010M -2.530M
Cash From Financing Activities 0.000 -20.00K 0.000
Net Change In Cash -380.0K -2.810M -4.390M
YoY Change -353.33% -35.99% 134.76%
FREE CASH FLOW
Cash From Operating Activities -$1.370M -$1.780M -$1.860M
Capital Expenditures $0.00 -$10.00K -$30.00K
Free Cash Flow -$1.370M -$1.770M -$1.830M
YoY Change -25.14% -3.28% -1.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001121702
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12519017 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
YIELD10 BIOSCIENCE, INC.
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
34000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
117000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
55000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
229000 USD
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
148000 USD
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
871000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3584000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11304000 USD
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9396124 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9278989 shares
CY2016Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
29622 sqft
CY2018Q2 us-gaap Assets
Assets
17220000 USD
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
998000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3023000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11518573 shares
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3252000 USD
CY2019Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
4250000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14804000 USD
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3500000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3355000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
680000 USD
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
586000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
234000 USD
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
169000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-110000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-118000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
357646000 USD
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
360516000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
315000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
596000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
275000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
349000 USD
CY2018Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11722414 shares
CY2018Q4 us-gaap Assets
Assets
12960000 USD
CY2019Q2 us-gaap Assets
Assets
11156000 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
10104000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
6377000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
5017000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2746000 USD
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
998000 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2746000 USD
CY2019Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7039784 shares
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9185222 shares
CY2019Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9485866 shares
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
us-gaap Lease Cost
LeaseCost
563000 USD
CY2019Q2 us-gaap Lease Cost
LeaseCost
231000 USD
us-gaap Lease Cost
LeaseCost
512000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10000 USD
CY2018Q2 us-gaap Lease Cost
LeaseCost
298000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 USD
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10025811 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12494731 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10025811 shares
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12494731 shares
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
125000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2403000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4699000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1874000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4139000 USD
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
2716000 USD
us-gaap Costs And Expenses
CostsAndExpenses
5093000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
2216000 USD
us-gaap Costs And Expenses
CostsAndExpenses
4625000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
96000 USD
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
98000 USD
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
217000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-6000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-4000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-42000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-62000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-54000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
54000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-926000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-102000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-22000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
37000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
56000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7705000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3082000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
998000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
969000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
939000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1080000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
637000 USD
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1644000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1735000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
7262000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6520000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
516000 USD
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
6061000 USD
CY2019Q2 us-gaap Liabilities
Liabilities
6702000 USD
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17220000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12960000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11156000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1641000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1506000 USD
CY2018Q4 us-gaap Long Term Investments
LongTermInvestments
0 USD
CY2019Q2 us-gaap Long Term Investments
LongTermInvestments
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
118000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2579000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4888000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4077000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-2393000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4685000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1871000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4131000 USD
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2393000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4685000 USD
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1871000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4131000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2431000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4748000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1898000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4183000 USD
CY2018Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
272000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
538000 USD
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
257000 USD
CY2018Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
739000 USD
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
844000 USD
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
865000 USD
CY2018Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6000000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5621000 USD
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5196000 USD
CY2018Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5209000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4766000 USD
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4467000 USD
CY2018Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0675
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0675
CY2018Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M24D
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y1M06D
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
298000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-14000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42000 USD
CY2018Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-9000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
164000 USD
CY2018Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
100000 USD
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-8000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-10000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-8000 USD
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
38000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
63000 USD
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
7986000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
998000 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
448000 USD
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
516000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2583000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1500000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2746000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
124000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1477000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1385000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1298000 USD
CY2018Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
332000 USD
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
332000 USD
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
332000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351938000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-356069000 USD
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
285000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
345000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
318000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
442000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
74000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2016Q4 us-gaap Security Deposit
SecurityDeposit
307000 USD
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1456000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2732000 USD
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1025000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2211000 USD
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
315000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
596000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
113000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
275000 USD
CY2018Q2 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
2703 shares
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
2703 shares
CY2019Q2 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
2449 shares
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
2449 shares
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
2746000 USD
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
998000 USD
CY2018Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
139000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
257000 USD
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
108000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
254000 USD
CY2018Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1772000 shares
CY2018Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
37000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
59000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
24000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
41000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2583000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-6000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-4000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
13502000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
11633000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
9576000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5698000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
6195000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
4454000 USD
CY2018Q2 us-gaap Sublease Income
SubleaseIncome
113000 USD
us-gaap Sublease Income
SubleaseIncome
232000 USD
CY2019Q2 us-gaap Sublease Income
SubleaseIncome
134000 USD
us-gaap Sublease Income
SubleaseIncome
258000 USD
CY2018Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
66000 USD
CY2019Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
103000 USD
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9991460 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9845902 shares
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12494337 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11504314 shares
CY2018Q4 yten Accrued Lease Cost
AccruedLeaseCost
50000 USD
CY2019Q2 yten Accrued Lease Cost
AccruedLeaseCost
36000 USD
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
70000 USD
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
49000 USD
CY2018Q2 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1260000 USD
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
2361000 USD
CY2019Q2 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1191000 USD
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
2414000 USD
yten Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
-162000 USD
yten Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
-404000 USD
CY2018Q2 yten Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
0 USD
CY2018Q4 yten Lease Incentive Payable Noncurrent
LeaseIncentivePayableNoncurrent
0 USD
yten Noncash Lease Expense Income
NoncashLeaseExpenseIncome
145000 USD
yten Noncash Lease Expense Income
NoncashLeaseExpenseIncome
299000 USD
CY2016 yten Operating Leases Landlord Reimbursement For Lease Improvements
OperatingLeasesLandlordReimbursementForLeaseImprovements
889000 USD
CY2016 yten Operatingleaseslandlordreimbforleaseimprovementsadditionalpayments
Operatingleaseslandlordreimbforleaseimprovementsadditionalpayments
444000 USD
CY2019Q2 yten Warrants Expired During Period
WarrantsExpiredDuringPeriod
393300 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents and investments. The Company has historically invested its cash equivalents in highly rated money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments, when purchased, are acquired in accordance with the Company&#8217;s investment policy which establishes a concentration limit per issuer.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of grant revenue and expenses during the reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0001121702-19-000025-index-headers.html Edgar Link pending
0001121702-19-000025-index.html Edgar Link pending
0001121702-19-000025.txt Edgar Link pending
0001121702-19-000025-xbrl.zip Edgar Link pending
ex-311x20190630.htm Edgar Link pending
ex-312x20190630.htm Edgar Link pending
ex-321x20190630.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yten-20190630.xml Edgar Link completed
yten-20190630.xsd Edgar Link pending
yten-20190630x10q.htm Edgar Link pending
yten-20190630_cal.xml Edgar Link unprocessable
yten-20190630_def.xml Edgar Link unprocessable
yten-20190630_lab.xml Edgar Link unprocessable
yten-20190630_pre.xml Edgar Link unprocessable